Nu Skin Enterprises (NYSE:NUS) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Nu Skin Enterprises (NYSE:NUS) from a hold rating to a buy rating in a research note published on Monday morning.

Nu Skin Enterprises Price Performance

NYSE NUS opened at $7.47 on Monday. The firm has a market capitalization of $371.18 million, a PE ratio of -2.53 and a beta of 0.92. Nu Skin Enterprises has a 12 month low of $5.32 and a 12 month high of $14.00. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17. The company’s 50 day simple moving average is $6.71 and its 200 day simple moving average is $6.95.

Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, May 8th. The company reported $0.23 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.08. The firm had revenue of $364.49 million during the quarter, compared to analysts’ expectations of $352.06 million. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. As a group, equities research analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 11th. Investors of record on Friday, May 30th will be issued a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 3.22%. The ex-dividend date of this dividend is Friday, May 30th. Nu Skin Enterprises’s payout ratio is -30.00%.

Institutional Trading of Nu Skin Enterprises

Large investors have recently added to or reduced their stakes in the business. Barclays PLC boosted its stake in Nu Skin Enterprises by 363.8% in the 3rd quarter. Barclays PLC now owns 85,437 shares of the company’s stock worth $629,000 after purchasing an additional 67,016 shares during the period. JPMorgan Chase & Co. boosted its stake in Nu Skin Enterprises by 175.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company’s stock worth $1,710,000 after purchasing an additional 147,784 shares during the period. Ballentine Partners LLC boosted its stake in Nu Skin Enterprises by 15.5% in the 4th quarter. Ballentine Partners LLC now owns 20,856 shares of the company’s stock worth $144,000 after purchasing an additional 2,800 shares during the period. Inspire Investing LLC boosted its stake in Nu Skin Enterprises by 7.8% in the 4th quarter. Inspire Investing LLC now owns 65,418 shares of the company’s stock worth $451,000 after purchasing an additional 4,728 shares during the period. Finally, Rhumbline Advisers boosted its stake in Nu Skin Enterprises by 70.9% in the 4th quarter. Rhumbline Advisers now owns 138,477 shares of the company’s stock worth $954,000 after purchasing an additional 57,443 shares during the period. 82.84% of the stock is currently owned by institutional investors.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.